Alert
March 23, 2022
Current Adoption of Connected Health Use Cases According to Life Science Executives Worldwide*, Nov 2021 (% of respondents)
Methodology
Data is from a March 2022 Capgemini report titled "Unlocking the Value in Connected Health." 523 executives, representing 166 companies from life sciences organizations in the pharmaceutical (59%) and biotechnology sectors (41%) in seven countries in North America, Europe, and Asia-Pacific were surveyed during October-November 2021. All respondents have indicated that their company is currently strategizing its approach to connected health, currently testing/developing connected health products, and/or currently have connected health products approved and in-market.Alert
Chart Title
Current Adoption of Connected Health Use Cases According to Life Science Executives Worldwide*, Nov 2021 (% of respondents)Publication Date
March 23, 2022
